Viewing Study NCT02971761


Ignite Creation Date: 2025-12-24 @ 12:07 PM
Ignite Modification Date: 2026-01-07 @ 2:23 PM
Study NCT ID: NCT02971761
Status: COMPLETED
Last Update Posted: 2024-02-20
First Post: 2016-11-21
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab and Enobosarm in Treating Patients With Androgen Receptor Positive Metastatic Triple Negative Breast Cancer
Sponsor: City of Hope Medical Center
Organization: